First in Man Study Investigating the Biodistribution, the Safety and Optimal Recommended Dose of a New Radiolabelled Monoclonal Antibody Targeting Frizzled Homolog 10
by on Friday, November 11th, 2011 | No Comments
Condition: Sarcoma, Synovial
Interventions: Drug: OTSA101-DTPA-90Y level 1; Drug: OTSA101-DTPA-90Y level 2; Drug: OTSA101-DTPA-90Y level 3
Sponsors: Centre Leon Berard; OncoTherapy Science, Inc.
Not yet recruiting – verified November 2011